In kids with a febrile urinary tract infection (UTI), an individualized duration of antibiotics led to an increased risk of recurrent UTI compared with a 10-day course. However, the individualized ...

The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to developer ...

A minor UTI can turn into a serious kidney or blood infection if you don't. Which antibiotic you get and how long you take it depends on your urine (pee) test results. Which medication and dose ...

Bacteria cause urinary tract infections (UTIs), so antibiotics are the first-line treatment. Even when symptoms disappear, a person should finish their antibiotic course according to their doctor ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...

The first new type of antibiotic developed in more than 20 years to treat urinary tract infections (UTIs) appears to be so effective that the pharmaceutical company stopped testing and will soon ...

paving the way for what could be the first new oral antibiotic for the common ailment in more than two decades. Around half of all women have suffered a urinary-tract infection, or UTI ...

If approved, the drug will be the first new treatment for uncomplicated urinary tract infections in more than 2 decades. GSK has stopped two phase 3 clinical trials for gepotidacin, a potential ...

The prompts also led to a 17% reduction among patients with UTI. Two studies assessing the use of algorithm-driven prompts meant to improve antibiotic selection for patients hospitalized with ...